scl-8k_20220727.htm
false 0000094049 0000094049 2022-07-27 2022-07-27

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): 07/27/2022

 

STEPAN COMPANY

(Exact name of registrant as specified in its charter)

 

Commission File Number: 1-4462

 

Delaware

 

36-1823834

(State or other jurisdiction of

incorporation)

 

(IRS Employer

Identification No.)

1101 Skokie Boulevard, Northbrook, Illinois 60062

(Address of principal executive offices, including zip code)

(847)446-7500

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Title of each class

 

 

Trading Symbol(s)

 

Name of Each exchange on which registered

 

Common Stock, $1 par value

 

SCL

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

 

 


 

 

Item 2.02.Results of Operations and Financial Condition

 

On July 27, 2022, Stepan Company (“Stepan”) issued a press release providing its financial results for the second quarter ended June 30, 2022.  A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.

 

In addition, on July 27, 2022, Stepan issued a press release announcing that its Board of Directors declared a quarterly cash dividend on its common stock of $0.335 per share.  The dividend will be paid on September 15, 2022, to common stockholders of record on August 31, 2022.  A copy of the press release is attached as Exhibit 99.2 hereto and incorporated herein by reference.

 

Item 9.01.Financial Statements and Exhibits

 

(d)

Exhibits

 

Exhibit Number: 99.1

Description: Press Release of Stepan Company dated July 27, 2022

 

Exhibit Number: 99.2

Description: Press Release of Stepan Company dated July 27, 2022

 

Exhibit Number:  104

Description:  Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 


 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

STEPAN COMPANY

Date: July 27, 2022  

 

 

 

 

By:

 

 

/s/ David G. Kabbes

 

 

 

 

 

 

David G. Kabbes

 

 

 

 

 

 

Vice President, General Counsel and Secretary

 

 

scl-ex991_16.htm

  

Exhibit 99.1

 

Stepan Reports Record Second Quarter Results and Record First Half Earnings

 

Northbrook, Illinois, July 27, 2022 -- Stepan Company (NYSE: SCL) today reported:

 

Second Quarter Highlights

 

 

Reported net income was a record $52.1 million, or $2.26 per diluted share, versus $43.3 million, or $1.85 per diluted share, in the prior year.  Adjusted net income* was a record $53.0 million, or $2.30 per diluted share, versus $42.2 million, or $1.81 per diluted share, in the prior year.  Total Company sales volume declined 1% versus the prior year.

 

 

 

Surfactant operating income was $48.2 million versus $45.9 million in the prior year. This increase was primarily driven by improved product and customer mix that was partially offset by a 3% decline in global sales volume.  The lower sales volume was driven by global commodity laundry products due to raw material and logistics constraints in North American and lower demand in Latin America.  Higher demand in the Functional Products, Personal Care and Institutional Cleaning end markets partially offset the above.  

 

 

 

Polymer operating income was a record $33.9 million versus $23.0 million in the prior year.  This increase was primarily attributable to margin recovery, improved mix and a 2% increase in global sales volume.  Global Rigid Polyol volume was up 5% versus the prior year driven by North American volume growth of 8%, partially offset by lower demand within the Phthalic Anhydride and Specialty Polyols businesses.

 

 

 

Specialty Product operating income was a record $9.9 million versus $7.0 million in the prior year.  This increase was primarily attributable to improved margins and customer mix within the medium chain triglycerides (MCTs) product line, partially offset by order timing differences within the food and flavor business.

 

 

 

The effect of foreign currency translation negatively impacted net income by $1.9 million, or $0.08 per diluted share, versus the prior year.

 

 

First Half Highlights

 

 

Reported net income was a record $96.9 million, or $4.19 per diluted share, versus $83.9 million, or $3.59 per diluted share, in the prior year.  Adjusted net income* was a record $93.7 million, or $4.05 per diluted share, versus $84.6 million, or $3.62 per diluted share, in the prior year.  Total Company sales volume was down 1% compared to the first six months of 2021.  A 2% decrease in global Surfactant sales volume was partially offset by a 2% increase in global Polymer sales volume.  

 

 

*

Adjusted net income is a non-GAAP measure which excludes deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, legacy environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.

 

 

1


 

 

“The Company had a strong first half performance and delivered record results despite ongoing supply chain challenges.  Reported net income was up 16% versus the first half of 2021 while adjusted net income was up 11%,” said Scott Behrens, President and Chief Executive Officer.  “For the quarter, Surfactant operating income was up 5% largely due to improved product and customer mix.  This improvement was driven by growth in our Functional Products business as a result of elevated crop and energy prices and continued growth in the construction industry, which offset a 3% decline in sales volume.  Our Polymer operating income was up 47% due to margin recovery, improved mix and 2% sales volume growth.  Our Specialty Product results improved primarily due to to margin improvement and favorable customer mix.”

 

Financial Summary

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands, except per share data)

2022

 

 

2021

 

 

%

Change

 

 

2022

 

 

2021

 

 

%

Change

 

Net Sales

$

751,633

 

 

$

595,511

 

 

 

26

%

 

$

1,426,909

 

 

$

1,133,251

 

 

 

26

%

Operating Income

$

77,640

 

 

$

56,657

 

 

 

37

%

 

$

140,986

 

 

$

110,571

 

 

 

28

%

Net Income Attributable to Stepan **

$

52,126

 

 

$

43,278

 

 

 

20

%

 

$

96,935

 

 

$

83,889

 

 

 

16

%

Earnings per Diluted Share

$

2.26

 

 

$

1.85

 

 

 

22

%

 

$

4.19

 

 

$

3.59

 

 

 

17

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income *

$

53,009

 

 

$

42,218

 

 

 

26

%

 

$

93,736

 

 

$

84,589

 

 

 

11

%

Adjusted Earnings per Diluted Share *

$

2.30

 

 

$

1.81

 

 

 

27

%

 

$

4.05

 

 

$

3.62

 

 

 

12

%

 

* See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.

** Net Income Attributable to Stepan = Net Income – Net Income Attributable to Noncontrolling Interests

 

 

Summary of Second Quarter Adjusted Net Income Items

 

Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.

 

 

Deferred Compensation:  The current year second quarter reported net income includes $0.5 million of after-tax expense versus $1.1 million of after-tax income in the prior year.  

 

 

Cash-Settled SARs:  These management incentive instruments provide cash to participants equal to the appreciation on the price of specified shares of Company stock over a specified period of time.  Because income or expense is recognized merely on the movement in the price of Company stock it has been excluded, similar to deferred compensation, to arrive at adjusted net income.  The current year second quarter includes $0.1 million of after-tax expense versus $0.1 million of after-tax income in the prior year.

 

 

Business Restructuring:  Both the current and prior year second quarters include $0.1 million of after-tax decommissioning expense related to the Company’s Canadian plant closure.

 

2


 

 

Environmental Remediation – The second quarter 2022 adjusted net income excludes $0.2 million of after-tax expense versus no environmental remediation expense excluded from adjusted net income in the prior year.

 

Percentage Change in Net Sales

 

Net sales in the second quarter of 2022 increased 26% year-over-year primarily due to higher selling prices that were mainly attributable to the pass-through of higher raw material and logistics costs and improved product and customer mix.  These higher average selling prices were partially offset by a 1% decrease in global sales volume and the unfavorable impact of foreign currency translation.    

 

 

 

Three Months Ended

June 30, 2022

 

 

Six Months Ended

June 30, 2022

 

Volume

 

 

(1

)%

 

 

(1

)%

Selling Price & Mix

 

 

32

%

 

 

30

%

Foreign Translation

 

 

(5

)%

 

 

(3

)%

Total

 

 

26

%

 

 

26

%

 

Segment Results

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2022

 

 

2021

 

 

%

Change

 

 

2022

 

 

2021

 

 

%

Change

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Surfactants

 

$

485,084

 

 

$

384,002

 

 

 

26

%

 

$

953,350

 

 

$

754,938

 

 

 

26

%

Polymers

 

$

238,885

 

 

$

190,538

 

 

 

25

%

 

$

425,964

 

 

$

340,923

 

 

 

25

%

Specialty Products

 

$

27,664

 

 

$

20,971

 

 

 

32

%

 

$

47,595

 

 

$

37,390

 

 

 

27

%

Total Net Sales

 

$

751,633

 

 

$

595,511

 

 

 

26

%

 

$

1,426,909

 

 

$

1,133,251

 

 

 

26

%

 

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2022

 

 

2021

 

 

%

Change

 

 

2022

 

 

2021

 

 

%

Change

 

Operating Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Surfactants

 

$

48,249

 

 

$

45,896

 

 

 

5

%

 

$

102,018

 

 

$

99,106

 

 

 

3

%

Polymers

 

$

33,912

 

 

$

23,025

 

 

 

47

%

 

$

48,041

 

 

$

40,976

 

 

 

17

%

Specialty Products

 

$

9,866

 

 

$

6,977

 

 

 

41

%

 

$

13,561

 

 

$

9,610

 

 

 

41

%

Total Segment Operating Income

 

$

92,027

 

 

$

75,898

 

 

 

21

%

 

$

163,620

 

 

$

149,692

 

 

 

9

%

Corporate Expenses

 

$

(14,387

)

 

$

(19,241

)

 

 

(25

)%

 

$

(22,634

)

 

$

(39,121

)

 

 

(42

)%

Consolidated Operating Income

 

$

77,640

 

 

$

56,657

 

 

 

37

%

 

$

140,986

 

 

$

110,571

 

 

 

28

%

 

 

Total segment operating income for the second quarter of 2022 increased $16.1 million, or 21%, versus the prior year quarter.  Total segment operating income in the first half of 2022 was up $13.9 million, or 9%, versus the prior year.

 

Surfactant net sales were $485.1 million for the quarter, a 26% increase versus the prior year.  Selling prices were up 32% primarily due to the pass-through of higher raw material and logistics costs as well as improved product and customer mix.  The unfavorable impact of foreign currency translation negatively impacted net sales by

3


3%.  Sales volume decreased 3% year-over-year primarily due to a decline in commodity laundry products sold within the Consumer Products business, mostly attributable to raw material and logistics constraints in North America and lower demand in Latin America.  Higher global demand for products sold into the Functional Products, Personal Care and Institutional Cleaning end markets largely offset the above.  Surfactant operating income for the quarter increased $2.4 million, or 5%, versus the prior year primarily due to improved product and customer mix that was partially offset by supply chain challenges and a 3% decline in sales volume.

 

Polymer net sales were $238.9 million for the quarter, a 25% increase versus the prior year.  Selling prices increased 30% primarily due to the pass through of higher raw material and logistics costs.  Sales volume increased 2% in the quarter primarily due to Rigid Polyol growth of 5% that was partially offset by lower demand within the Phthalic Anhydride and Specialty Polyols businesses.  The translation impact of a stronger U.S. dollar negatively impacted net sales by 7%.  Polymer operating income increased $10.9 million, or 47%, primarily due to margin recovery and the 2% sales volume growth.

 

Specialty Product net sales were $27.7 million for the quarter, a 32% increase versus the prior year.  Sales volume was down 7% between years while operating income improved $2.9 million, or 41%.  The operating income improvement was primarily attributable to improved margins within the MCTs product line and more favorable customer mix, partially offset by order timing differences within the food and flavor business.

 

 

Corporate Expenses

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2022

 

 

2021

 

 

%

Change

 

 

2022

 

 

2021

 

 

%

Change

 

Total Corporate Expenses

 

$

14,387

 

 

$

19,241

 

 

 

(25

)%

 

$

22,634

 

 

$

39,121

 

 

 

(42

)%

Excluded Items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred Compensation

 

$

3,406

 

 

$

(958

)

 

NM

 

 

$

10,907

 

 

$

(3,652

)

 

NM

 

     Business Restructuring

 

$

(81

)

 

$

(114

)

 

 

(29

)%

 

$

(133

)

 

$

(195

)

 

 

(32

)%

Adjusted Corporate Expense

 

$

17,712

 

 

$

18,169

 

 

 

(3

)%

 

$

33,408

 

 

$

35,274

 

 

 

(5

)%

 

* See Table III for a discussion of deferred compensation plan accounting.

    

Corporate expenses, excluding deferred compensation and business restructuring costs, decreased $0.5 million, or 3%, versus the prior year quarter.  This decrease was primarily due to lower acquisition-related expenses that were partially offset by higher incentive-based compensation expenses.

  

Income Taxes

 

The Company’s effective tax rate was 24.8% in the first half of 2022 versus 24.4% in the first half of 2021.  This year-over-year increase was primarily attributable to a less favorable geographical mix of income and less favorable tax benefits derived from stock-based compensation awards in the first half of 2022 versus the first half of 2021.

 

4


 

Shareholder Return

 

The Company paid $7.5 million of dividends to shareholders and repurchased $7.0 million of Company stock in the second quarter of 2022.  During the first six months of 2022 the Company paid $15.0 million of dividends and repurchased $17.0 million of Company stock.  The Company has $133.0 million remaining under the share repurchase program authorized by its Board of Directors.  The Company has increased its dividend on the Company’s common stock for 54 consecutive years.

 

Selected Balance Sheet Information

 

The Company’s total debt decreased by $11.1 million and cash decreased by $41.4 million versus March 31, 2022.  The decrease in debt primarily reflects scheduled debt repayments in June 2022.  The decrease in cash primarily reflects the scheduled debt repayments plus higher working capital requirements and capital expenditures. The Company’s net debt level increased $30.3 million versus March 31, 2022 and the net debt ratio increased from 21% to 23% in the quarter (Net Debt and Net Debt Ratio are non-GAAP measures).

 

    

 

($ in millions)

6/30/22

 

 

3/31/22

 

 

12/31/21

 

Net Debt

 

 

 

 

 

 

 

 

 

 

 

Total Debt

$

526.0

 

 

$

537.1

 

 

$

363.6

 

Cash

 

194.6

 

 

 

236.0

 

 

 

159.2

 

Net Debt

$

331.4

 

 

$

301.1

 

 

$

204.4

 

Equity

 

1,125.7

 

 

 

1,116.7

 

 

 

1,074.2

 

Net Debt + Equity

$

1,457.1

 

 

$

1,417.8

 

 

$

1,278.6

 

Net Debt / (Net Debt + Equity)

 

23

%

 

 

21

%

 

 

16

%

 

The major working capital components were:

 

($ in millions)

6/30/22

 

 

3/31/22

 

 

12/31/21

 

Net Receivables

$

518.8

 

 

$

504.5

 

 

$

419.5

 

Inventories

 

340.7

 

 

 

308.4

 

 

 

305.5

 

Accounts Payable

 

(366.2

)

 

 

(350.8

)

 

 

(323.4

)

Total

$

493.3

 

 

$

462.1

 

 

$

401.6

 

 

Capital spending was $69.2 million during the quarter and $129.5 million during the first half of 2022.  This compares to $37.3 million and $74.9 million, respectively, in the prior year.  The year-over-year increase is primarily due to increased expenditures in the U.S. for the advancement of the Company’s new alkoxylation facility in Pasadena, TX, which is expected provide flexible capacity of 75,000 metric tons per year, and new capability and capacity to produce ether sulfates that will meet upcoming regulatory limits on 1,4 dioxane.  For the full year, capital expenditures are expected to be in the range of $350 million to $375 million.  

 

Outlook

 

“The Company delivered record earnings for the second quarter and the first half of 2022,” said Scott Behrens, President and Chief Executive Officer.  “Looking forward, we believe demand across our business should remain healthy but the Company will continue to be challenged by inflation, raw material and logistics constraints.  From a segment perspective, we believe that Surfactant volumes within the Functional Products end

5


markets will show full year growth over 2021 supported by continued elevated crop and energy prices.  We believe Polymers will deliver growth versus the prior year as energy conservation efforts and more stringent building codes should have a continued positive impact on demand for our Rigid polyols.  Specialty Product results should show year over year improvement as well.   We remain cautiously optimistic about the remainder of the year despite the current inflationary environment and ongoing supply chain challenges.”

 

Conference Call

 

Stepan Company will host a conference call to discuss the second quarter results at 10:00 a.m. ET (9:00 a.m. CT) on July 27, 2022. The call can be accessed by phone and webcast. Telephone access will be available by dialing 800-954-0624, and the webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

 

Supporting Slides

 

Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.

 

Corporate Profile

 

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

 

Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

 

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

 

More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com

 

Contact: Luis E. Rojo 847-446-7500

 

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company

6


and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

 

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition;

 

volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

 

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

* * * * *

 

Tables follow

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7


 

Table I

STEPAN COMPANY

For the Three and Six Months Ended June 30, 2022 and 2021

(Unaudited – ‘000’s Omitted)

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net Sales

 

$

751,633

 

 

$

595,511

 

 

$

1,426,909

 

 

$

1,133,251

 

Cost of Sales

 

 

620,019

 

 

 

483,830

 

 

 

1,186,076

 

 

 

912,590

 

Gross Profit

 

 

131,614

 

 

 

111,681

 

 

 

240,833

 

 

 

220,661

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 

15,552

 

 

 

14,990

 

 

 

30,829

 

 

 

29,494

 

Administrative

 

 

24,079

 

 

 

23,974

 

 

 

45,651

 

 

 

46,612

 

Research, Development and Technical Services

 

 

16,690

 

 

 

14,988

 

 

 

33,163

 

 

 

30,137

 

Deferred Compensation (Income) Expense

 

 

(3,406

)

 

 

958

 

 

 

(10,907

)

 

 

3,652

 

 

 

 

52,915

 

 

 

54,910

 

 

 

98,736

 

 

 

109,895

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Goodwill Impairment

 

 

978

 

 

 

-

 

 

 

978

 

 

 

-

 

Business Restructuring

 

 

81

 

 

 

114

 

 

 

133

 

 

 

195

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

 

77,640

 

 

 

56,657

 

 

 

140,986

 

 

 

110,571

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest, Net

 

 

(2,727

)

 

 

(1,567

)

 

 

(5,033

)

 

 

(3,091

)

Other, Net

 

 

(5,369

)

 

 

2,758

 

 

 

(7,019

)

 

 

3,504

 

 

 

 

(8,096

)

 

 

1,191

 

 

 

(12,052

)

 

 

413

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Before Income Taxes

 

 

69,544

 

 

 

57,848

 

 

 

128,934

 

 

 

110,984

 

Provision for Income Taxes

 

 

17,418

 

 

 

14,545

 

 

 

31,999

 

 

 

27,070

 

Net Income

 

 

52,126

 

 

 

43,303

 

 

 

96,935

 

 

 

83,914

 

Net Income Attributable to Noncontrolling Interests

 

 

-

 

 

 

(25

)

 

 

-

 

 

 

(25

)

Net Income Attributable to Stepan Company

 

$

52,126

 

 

$

43,278

 

 

$

96,935

 

 

$

83,889

 

Net Income Per Common Share Attributable to Stepan Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

2.29

 

 

$

1.89

 

 

$

4.24

 

 

$

3.65

 

Diluted

 

$

2.26

 

 

$

1.85

 

 

$

4.19

 

 

$

3.59

 

Shares Used to Compute Net Income Per Common

Share Attributable to Stepan Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

22,792

 

 

 

22,952

 

 

 

22,842

 

 

 

22,963

 

Diluted

 

 

23,055

 

 

 

23,345

 

 

 

23,115

 

 

 

23,338

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8


 

Table II

 

Reconciliations of Non-GAAP Net Income and Earnings per Diluted Share *

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands, except per share amounts)

 

2022

 

 

EPS

 

 

2021

 

 

EPS

 

 

2022

 

 

EPS

 

 

2021

 

 

EPS

 

Net Income Reported

 

$

52,126

 

 

$

2.26

 

 

$

43,278

 

 

$

1.85

 

 

$

96,935

 

 

$

4.19

 

 

$

83,889

 

 

$

3.59

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred Compensation (Income) Expense

 

$

518

 

 

$

0.02

 

 

$

(1,050

)

 

$

(0.04

)

 

$

(3,431

)

 

$

(0.15

)

 

$

451

 

 

$

0.02

 

Business Restructuring Expense

 

$

61

 

 

$

0.01

 

 

$

85

 

 

$

0.00

 

 

$

100

 

 

$

0.01

 

 

$

146

 

 

$

0.01

 

Cash-Settled SARs (Income) Expense

 

$

55

 

 

$

0.00

 

 

$

(95

)

 

$

(0.00

)

 

$

(347

)

 

$

(0.02

)

 

$

103

 

 

$

0.00

 

Environmental Remediation Expense

 

$

249

 

 

$

0.01

 

 

$

-

 

 

$

-

 

 

$

479

 

 

$

0.02

 

 

$

-

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income

 

$

53,009

 

 

$

2.30

 

 

$

42,218

 

 

$

1.81

 

 

$

93,736

 

 

$

4.05

 

 

$

84,589

 

 

$

3.62

 

 

* All amounts in this table are presented after-tax

 

The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items.  Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators.  These measures should be considered in addition to, and neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.

 

Reconciliation of Pre-Tax to After-Tax Adjustments

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands, except per share amounts)

 

2022

 

 

EPS

 

 

2021

 

 

EPS

 

 

2022

 

 

EPS

 

 

2021

 

 

EPS

 

Pre-Tax Adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred Compensation (Income) Expense

 

$

681

 

 

 

 

 

 

$

(1,381

)

 

 

 

 

 

$

(4,514

)

 

 

 

 

 

$

594

 

 

 

 

 

Business Restructuring Expense

 

$

81

 

 

 

 

 

 

$

114

 

 

 

 

 

 

$

133

 

 

 

 

 

 

$

195

 

 

 

 

 

Cash-Settled SARs (Income) Expense

 

$

73

 

 

 

 

 

 

$

(125

)

 

 

 

 

 

$

(455

)

 

 

 

 

 

$

136

 

 

 

 

 

Environmental Remediation Expense

 

$

327

 

 

 

 

 

 

$

-

 

 

 

 

 

 

$

630

 

 

 

 

 

 

$

-

 

 

 

 

 

   Total Pre-Tax Adjustments

 

$

1,162

 

 

 

 

 

 

$

(1,392

)

 

 

 

 

 

$

(4,206

)

 

 

 

 

 

$

925

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative Tax Effect on Adjustments

 

$

(279

)

 

 

 

 

 

$

332

 

 

 

 

 

 

$

1,007

 

 

 

 

 

 

$

(225

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

After-Tax Adjustments

 

$

883

 

 

$

0.04

 

 

$

(1,060

)

 

$

(0.04

)

 

$

(3,199

)

 

$

(0.14

)

 

$

700

 

 

$

0.03

 

 

 

 

 

9


 

Table III

 

 

Deferred Compensation Plans

 

 

The full effect of deferred compensation plans on quarterly pre-tax income was $0.7 million of expense versus $1.4 million of income in the prior year. The year-to-date impact was $4.5 million of income versus $0.6 million of expense in the prior year. The accounting for deferred compensation plans results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The quarter end market prices of Company common stock were as follows:

 

 

 

2022

 

 

2021

 

 

 

12/31

 

9/30

 

6/30

 

 

3/31

 

 

12/31

 

 

9/30

 

 

6/30

 

 

3/31

 

Stepan Company

 

N/A

 

N/A

 

$

101.35

 

 

$

98.81

 

 

$

124.29

 

 

$

112.94

 

 

$

120.27

 

 

$

127.11

 

 

 

The deferred compensation income statement impact is summarized below:

 

 

 

Three Months Ended

June 30

 

 

Six Months Ended

June 30

 

($ in thousands)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Deferred Compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income (Expense)

 

$

3,406

 

 

$

(958

)

 

$

10,907

 

 

$

(3,652

)

Other, net – Mutual Fund Gain (Loss)

 

 

(4,087

)

 

 

2,339

 

 

 

(6,393

)

 

 

3,058

 

Total Pretax

 

$

(681

)

 

$

1,381

 

 

$

4,514

 

 

$

(594

)

Total After Tax

 

$

(518

)

 

$

1,050

 

 

$

3,431

 

 

$

(451

)

 

 

 

 


10


 

Table IV

 

 

Effects of Foreign Currency Translation

 

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results).  Below is a table that presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the three and six month periods ending June 30, 2022 as compared to 2021:

 

($ in millions)

 

Three Months Ended

June 30

 

 

Increase

 

 

Change

Due to Foreign

Currency

Translation

 

 

Six Months Ended

June 30

 

 

Increase

 

 

Change

Due to Foreign

Currency

Translation

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

Net Sales

 

$

751.6

 

 

$

595.5

 

 

$

156.1

 

 

$

(25.6

)

 

$

1,426.9

 

 

$

1,133.3

 

 

$

293.6

 

 

$

(37.3

)

Gross Profit

 

 

131.6

 

 

 

111.7

 

 

 

19.9

 

 

 

(3.5

)

 

 

240.8

 

 

 

220.7

 

 

 

20.1

 

 

 

(5.2

)

Operating Income

 

 

77.6

 

 

 

56.7

 

 

 

20.9

 

 

 

(2.5

)

 

 

141.0

 

 

 

110.6

 

 

 

30.4

 

 

 

(3.6

)

Pretax Income

 

 

69.5

 

 

 

57.8

 

 

 

11.7

 

 

 

(2.5

)

 

 

128.9

 

 

 

111.0

 

 

 

17.9

 

 

 

(3.7

)

 

 


11


 

Table V

 

 

Stepan Company

Consolidated Balance Sheets

June 30, 2022 and December 31, 2021

 

 

 

June 30, 2022

 

 

December 31, 2021

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

$

1,087,367

 

 

$

913,368

 

Property, Plant & Equipment, Net

 

 

919,534

 

 

 

850,604

 

Other Assets

 

 

281,898

 

 

 

301,640

 

Total Assets

 

$

2,288,799

 

 

$

2,065,612

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities

 

$

638,228

 

 

$

500,476

 

Deferred Income Taxes

 

 

11,375

 

 

 

12,491

 

Long-term Debt

 

 

383,503

 

 

 

322,862

 

Other Non-current Liabilities

 

 

129,982

 

 

 

155,590

 

Total Stepan Company Stockholders’ Equity

 

 

1,125,711

 

 

 

1,074,193

 

Noncontrolling Interest

 

 

-

 

 

 

-

 

Total Liabilities and Stockholders’ Equity

 

$

2,288,799

 

 

$

2,065,612

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12

scl-ex992_15.htm

Exhibit 99.2

 

Stepan Declares Quarterly Dividend

 

Northbrook, Illinois, July 27, 2022 -- Stepan Company (NYSE:SCL) today reported:

 

On July 26, 2022, the Board of Directors of Stepan Company declared a quarterly cash dividend on the Company’s common stock of $0.335 per share.  The dividend is payable on September 15, 2022, to common stockholders of record on August 31, 2022. The Company increased its quarterly cash dividend in the fourth quarter of 2021 by $0.030 per share, marking the 54th consecutive year that the Company has increased its cash dividend to stockholders.  

 

Corporate Profile

 

 

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

 

Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

 

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com.

 

More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com.

 

Contact: Luis E. Rojo 847-446-7500

 

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

 

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking


statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

 

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.